These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29903935)

  • 1. O-linked mucin-type glycosylation in breast cancer.
    Burchell JM; Beatson R; Graham R; Taylor-Papadimitriou J; Tajadura-Ortega V
    Biochem Soc Trans; 2018 Aug; 46(4):779-788. PubMed ID: 29903935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
    Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
    J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
    Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
    Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Close Relationship between the Golgi Trafficking Machinery and Protein Glycosylation.
    Frappaolo A; Karimpour-Ghahnavieh A; Sechi S; Giansanti MG
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-linked mucin-type glycosylation regulates the transcriptional programme downstream of EGFR.
    Tajadura-Ortega V; Gambardella G; Skinner A; Halim A; Van Coillie J; Schjoldager KTG; Beatson R; Graham R; Achkova D; Taylor-Papadimitriou J; Ciccarelli FD; Burchell JM
    Glycobiology; 2021 Apr; 31(3):200-210. PubMed ID: 32776095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.
    Brockhausen I
    EMBO Rep; 2006 Jun; 7(6):599-604. PubMed ID: 16741504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-linked glycosylation in the mammary gland: changes that occur during malignancy.
    Burchell JM; Mungul A; Taylor-Papadimitriou J
    J Mammary Gland Biol Neoplasia; 2001 Jul; 6(3):355-64. PubMed ID: 11547903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered O-linked glycosylation in benign and malignant meningiomas.
    Talabnin C; Trasaktaweesakul T; Jaturutthaweechot P; Asavaritikrai P; Kongnawakun D; Silsirivanit A; Araki N; Talabnin K
    PeerJ; 2024; 12():e16785. PubMed ID: 38274327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins.
    Axelsson MA; Karlsson NG; Steel DM; Ouwendijk J; Nilsson T; Hansson GC
    Glycobiology; 2001 Aug; 11(8):633-44. PubMed ID: 11479274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
    Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
    Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese ion concentration affects production of human core 3 O-glycan in Saccharomyces cerevisiae.
    Saito F; Sakamoto I; Kanatani A; Chiba Y
    Biochim Biophys Acta; 2016 Sep; 1860(9):1809-20. PubMed ID: 27259834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
    Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
    Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple sugars to complex disease--mucin-type O-glycans in cancer.
    Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
    Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis Infection Manipulates the Glycosylation Machinery and the N-Glycoproteome of Human Macrophages and Their Microparticles.
    Hare NJ; Lee LY; Loke I; Britton WJ; Saunders BM; Thaysen-Andersen M
    J Proteome Res; 2017 Jan; 16(1):247-263. PubMed ID: 27760463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation pathways at the ocular surface.
    Rodriguez Benavente MC; Argüeso P
    Biochem Soc Trans; 2018 Apr; 46(2):343-350. PubMed ID: 29523772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of glycosylation using Drosophila melanogaster.
    Nishihara S
    Glycoconj J; 2020 Feb; 37(1):1-14. PubMed ID: 31773367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mucin-type O-glycosylation through metabolic processing and incorporation of N-thioglycolyl-D-galactosamine peracetate (Ac5GalNTGc).
    Agarwal K; Kaul R; Garg M; Shajahan A; Jha SK; Sampathkumar SG
    J Am Chem Soc; 2013 Sep; 135(38):14189-97. PubMed ID: 23987472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can yeast tell us about N-linked glycosylation in the Golgi apparatus?
    Munro S
    FEBS Lett; 2001 Jun; 498(2-3):223-7. PubMed ID: 11412862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
    Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
    J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Fang R; Xu F; Shi H; Wu Y; Cao C; Li H; Ye K; Zhang Y; Liu Q; Zhang S; Zhang W; Ye L
    Oncogene; 2020 Mar; 39(11):2290-2304. PubMed ID: 31836847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.